I know £NVAX has had a bit of a torrid time with their production etc but it now seems to be turning the corner. EU is granting authorisation and the big one (the US FDA) has a meeting on June 7th to consider authorisation again. This on the back of the FDA severely restricting the use of the J&J vaccine due to the same rare blood clotting issue seen with the Astrazenica vaccine. It's almost like the US needs the Novavax protein based vaccine and the timing couldn't have come sooner assuming the FDA does give approval. It's been approved in the UK and now the EU of late although the FDA can be a bit more stringent.
At the current price, it looks ok to me. Wondering what others think?
